Ni ibẹrẹ Oṣu Kẹjọ, idanwo antigen INNOVITA 2019-nCoV jẹ ifọwọsi nipasẹ Ile-iṣẹ Aabo ti Orilẹ-ede Faranse ati Awọn Ọja Ilera (ANSM) ati Igbimọ Ounjẹ ati Oògùn Thailand (Thai FDA), lẹhinna, idanwo INNOVITA Covid-19 ti forukọsilẹ ni o fẹrẹ to 30 awọn orilẹ-ede.
Awọn orilẹ-ede wọnyi pẹlu China, United States, Brazil, France, Italy, Russia, Spain, Portugal, Netherlands, Hungary, Austria, Sweden, Singapore, Philippines, Malaysia, Thailand, Argentina, Ecuador, Colombia, Peru, Chile, Mexico Ni lọwọlọwọ, INNOVITA tun nbere fun iwe-ẹri CE ati iforukọsilẹ ti US FDA COVID-19 antigen test, lati mu yara imugboroosi ti iwọn iforukọsilẹ okeokun ti awọn ohun elo idanwo COVID-19.
Lẹhin ti okeere si awọn orilẹ-ede ti o wa loke, INNOVITA pese deede, iyara ati iwadii iwọn-nla ti awọn akoran COVID-19 ti ṣe ipa pataki ninu igbejako COVID-19 ni orilẹ-ede kọọkan.
Lẹhin ibesile ti COVID-19 ni ọdun 2020, INNOVITA dahun ni iyara ati firanṣẹ awọn oṣiṣẹ R&D olokiki lati ṣe iwadii imọ-jinlẹ ni ọsan ati alẹ, ati ni aṣeyọri ni idagbasoke ohun elo idanwo ọlọjẹ aramada coronavirus (2019-nCoV) ati pe o fọwọsi nipasẹ NMPA.INNOVITA wa laarin awọn ile-iṣẹ akọkọ ni Ilu China lati gba ijẹrisi iforukọsilẹ ti ohun elo idanwo antibody COVID-19.Awọn ọja ni bayi ti wa ni tita daradara mejeeji ni ile ati ni okeere, ṣe idasi pupọ lori ija ajakale-arun naa.Ni Oṣu Kẹsan ọdun 2020, INNOVITA fun ni “Akojọpọ Ilọsiwaju ti Orilẹ-ede” ni apejọ iyìn ti Orilẹ-ede fun igbejako ajakaye-arun COVID-19.Ni Oṣu Kini Ọjọ 26, Ọdun 2021, Ile-iṣẹ ti Imọ-ẹrọ ati Imọ-ẹrọ tun fi lẹta ọpẹ ranṣẹ si INNOVITA fun atilẹyin ninu iṣẹ iwadii pajawiri lati ja ajakale-arun na.
Ni ọjọ iwaju, INNOVITA yoo tẹsiwaju lati lo anfani imọ-ẹrọ rẹ ati didara to dara, ṣawari ọja agbaye ati ṣe alabapin si Agbara China lori ija ajakale-arun ni kariaye!
Akoko ifiweranṣẹ: Oṣu Kẹwa 18-2021